Alzheimeri tõve geneetikast ja patofüsioloogiast
1. Pagon RA, Bird TD, Dolan CR, Stephens K. 1993-2010. Alzheimer Disease Overview. In
GeneReviews[Internet]. University of Washington, Seattle
Kättesaadav: http://www.ncbi.nlm.nih.gov/books/NBK1161
2. Kantor D,Zieve D. 2010. Alzheimer's disease.
Kättesaadav: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001767
3. F00-F09 Orgaanilised-k.a. sümptomaatilised- psüühikahäired
Kättesaadav: http://www.kliinikum.ee/psyhhiaatriakliinik/lisad/ravi/RHK/F0.htm
4. Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, Schneider LS. 2003. A
critical analysis of new molecular targets and strategies for drug developments in Alzheimer's
disease. Current Drug Targets 4, 97-112.
5. Terry AV, Buccafusco JJ. 2003. The cholinergic hypothesis of age and Alzheimer's disease-
related cognitive deficits: recent challenges and their implications for novel drug
development.The journal of pharmacology and experimental therapeutics 306 (3), 821-827.
6
annaabi.ee 
